[ NATIONAL · SA ]
A food and drug authority regulating medicines, devices and food under a single body rather than three.
SPEQ synthesis for orientation. It does not determine what applies to a specific product, and an adopted version can move without this page moving with it. Confirm the instrument in force with the authority before relying on it.
MIDDLE EAST & AFRICA
The Law of the Saudi Food and Drug Authority, issued under Royal Decree No. M/108 dated 19/11/1444 AH — June 2023 — which establishes the authority as an independent regulator with authority across food, drugs, medical devices, cosmetics and related products. Manufacturers, importers, distributors, wholesalers and pharmacies all operate under licences the authority issues.
Through licences granted by a single authority whose remit crosses product families that are usually split between separate regulators. Requirements attach to the licence and to product registration, and because one body holds food, medicines, devices and cosmetics, its expectations reach across a company’s whole portfolio rather than one part of it.
WHAT TRANSFERS
PIC/S evidence is recognisable. Saudi Arabia participates in PIC/S, so an inspection outcome from another participating authority is legible and can support the assessment. SPEQ has not decoded ICH participation, so the dossier should be built against the authority’s own requirements rather than assumed to follow an ICH-region submission. The licences themselves are Saudi and require a local presence to hold them.
Food, medicines, devices and cosmetics sit with one regulator. For a single-product company this simplifies; for a diversified one it means the regulator holds a consolidated view of the organisation, and inconsistency between submissions is visible in a way it would not be elsewhere.
Supplying the market requires an authorised local entity or representative alongside product registration. That relationship is a regulatory dependency, not only a commercial one, and changing it is a regulatory event.
Royal Decree M/108 restated the authority’s legal foundation in 2023. Guidance and secondary requirements written before it should be read against the current law rather than assumed to survive it unchanged.
Manufacturers, importers, distributors, wholesalers and pharmacies each hold a licence. A supply chain into this market is a chain of licensed parties, and a gap at any tier is a supply interruption.
The Law of the Saudi Food and Drug Authority, issued under Royal Decree No. M/108 dated 19/11/1444 AH, corresponding to June 2023. It establishes the authority as an independent regulator across food, drugs, medical devices and cosmetics.
Manufacturers, importers, distributors, wholesalers and pharmacies. Each tier of the supply chain holds its own licence, so a gap at any tier interrupts supply.
Yes. That single remit is the defining structural feature of this market. It simplifies matters for a company with one product family and raises the stakes on cross-submission consistency for a company with several.
ADOPTED, AT A PINNED VERSION
SPEQ has not decoded a pinned adoption edge here yet. That is a gap in this catalog, not a finding about Saudi Arabia: requirements still arrive through the authorities below, and the edition in force is theirs to state.
Participation changes which evidence transfers, and which edition of a harmonized guide the local instrument is likely to pin.